Skip To Content
Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site

Use of Specific Hallucinogens: 2006

The NSDUH Report: Use of Specific Hallucinogens: 2006

  • HTML format (508 compliant version - -also contains the data table that was used to construct each figure; this data table is not found in printed or PDF version)

Highlights:

  • Hallucinogens include lysergic acid diethylamide (LSD), phencyclidine (PCP), Ecstasy (MDMA), Salvia divinorum, ketamine, peyote, mescaline, and psilocybin (mushrooms). Specific questions on the following hallucinogens were first collected in SAMHSA's 2006 National Survey on Drug Use and Health: ketamine, dimethyltryptamine (DMT), alpha-methyltryptamine (AMT), 5-methoxy-diisopropyltryptamine (5-MeO-DIPT or "Foxy"), and Salvia divinorum.
  • Based on SAMHSA's 2006 National Survey on Drug Use and Health of persons aged 12 or older, 23 million had used LSD, 6.6 million used PCP, 2.3 used ketamine, 1.8 million used Salvia divinorum and 0.7 million had used DMT, AMT, or Foxy at least once in their lifetime.
  • Among youth aged 12 to 17, females were more likely than males to have used Ecstasy in the past year (1.4% vs. 1.0%).
  • Among youth aged 12 to 17, males were more likely than females to have used Salvia divinorum in the past year (0.9% vs. 0.3%)
  • In 2006, young adults aged 18 to 25 were more likely than youths aged 12 to 17 or adults aged 26 or older to be past year users of LSD, Ecstasy, and Salvia divinorum.

    Hallucinogens

Other drugs

Other topics

This Short Report, The NSDUH Report: Use of Specific Hallucinogens: 2006, is based on SAMHSA's National Survey on Drug Use and Health (NSDUH).  The survey is conducted by the Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA).  SAMHSA's National Survey on Drug Use and Health (NSDUH) is the primary source of information on the prevalence, patterns, and consequences of drug and alcohol use and abuse and for selected mental health measures in the general U.S. civilian non institutionalized population, age 12 and older.   SAMHSA's National Survey on Drug Use & Health also provides estimates for drug use and for selected mental health measures by State.

This is the page footer.

This page has been accessed 34505 times since 2/14/08.

This page was last updated on February 14, 2008.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

Yellow Line

Site Map | Contact Us | Accessibility Privacy PolicyFreedom of Information ActDisclaimer  |  Department of Health and Human ServicesSAMHSAWhite HouseUSA.gov

* Adobe™ PDF and MS Office™ formatted files require software viewer programs to properly read them. Click here to download these FREE programs now

What's New

Highlights Topics Data Drugs Pubs Short Reports Treatment Help Mail OAS